First-line ceritinib versus platinum-based chemotherapy in advanced ALK -rearranged non-small-cell lung cancer (ASCEND-4): a randomised, open-label, phase 3 study

Soria, Jean-Charles, Prof ; Tan, Daniel S W, MD ; Chiari, Rita, MD ; Wu, Yi-Long, Prof ; Paz-Ares, Luis, Prof ; Wolf, Juergen, Prof ; Geater, Sarayut L, MD ; Orlov, Sergey, Prof ; Cortinovis, Diego, MD ; Yu, Chong-Jen, Prof ; Hochmair, Maximillian, MD ; Cortot, Alexis B, Prof ; Tsai, Chun-Ming, Prof ; Moro-Sibilot, Denis, MD ; Campelo, Rosario G, MD ; McCulloch, Tracey, MSc ; Sen, Paramita, PhD ; Dugan, Margaret, MD ; Pantano, Serafino, PhD ; Branle, Fabrice, MD ; Massacesi, Cristian, MD ; de Castro, Gilberto, MD

The Lancet (British edition), 2017-03, Vol.389 (10072), p.917-929 [Periódico revisado por pares]

England: Elsevier Ltd

Texto completo disponível